These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

524 related items for PubMed ID: 2564423

  • 1. Synthesis and release of dopamine in rat brain: comparison between substantia nigra pars compacts, pars reticulata, and striatum.
    Nissbrandt H, Sundström E, Jonsson G, Hjorth S, Carlsson A.
    J Neurochem; 1989 Apr; 52(4):1170-82. PubMed ID: 2564423
    [Abstract] [Full Text] [Related]

  • 2. The effects of GBR 12909, a dopamine re-uptake inhibitor, on monoaminergic neurotransmission in rat striatum, limbic forebrain, cortical hemispheres and substantia nigra.
    Nissbrandt H, Engberg G, Pileblad E.
    Naunyn Schmiedebergs Arch Pharmacol; 1991 Jul; 344(1):16-28. PubMed ID: 1663587
    [Abstract] [Full Text] [Related]

  • 3. Effects of d-amphetamine on dopaminergic neurotransmission; a comparison between the substantia nigra and the striatum.
    Elverfors A, Nissbrandt H.
    Neuropharmacology; 1992 Jul; 31(7):661-70. PubMed ID: 1328918
    [Abstract] [Full Text] [Related]

  • 4. Turnover of dopamine and dopamine metabolites in rat brain: comparison between striatum and substantia nigra.
    Nissbrandt H, Carlsson A.
    J Neurochem; 1987 Sep; 49(3):959-67. PubMed ID: 3612134
    [Abstract] [Full Text] [Related]

  • 5. Evidence for dopamine release and metabolism beyond the control of nerve impulses and dopamine receptors in rat substantia nigra.
    Nissbrandt H, Pileblad E, Carlsson A.
    J Pharm Pharmacol; 1985 Dec; 37(12):884-9. PubMed ID: 2868096
    [Abstract] [Full Text] [Related]

  • 6. Neurochemical studies on central dopamine neurons--regional characterization of dopamine turnover.
    Hallman H, Jonsson G.
    Med Biol; 1984 Dec; 62(3):198-209. PubMed ID: 6492900
    [Abstract] [Full Text] [Related]

  • 7. 3-Methoxytyramine formation following monoamine oxidase inhibition is a poor index of dendritic dopamine release in the substantia nigra.
    Elverfors A, Pileblad E, Lagerkvist S, Bergquist F, Jonason J, Nissbrandt H.
    J Neurochem; 1997 Oct; 69(4):1684-92. PubMed ID: 9326297
    [Abstract] [Full Text] [Related]

  • 8. Reserpine-insensitive dopamine release in the substantia nigra?
    Elverfors A, Nissbrandt H.
    Brain Res; 1991 Aug 23; 557(1-2):5-12. PubMed ID: 1720998
    [Abstract] [Full Text] [Related]

  • 9. Striatal serotonin 2C receptors decrease nigrostriatal dopamine release by increasing GABA-A receptor tone in the substantia nigra.
    Burke MV, Nocjar C, Sonneborn AJ, McCreary AC, Pehek EA.
    J Neurochem; 2014 Nov 23; 131(4):432-43. PubMed ID: 25073477
    [Abstract] [Full Text] [Related]

  • 10. Amphetamine-induced dopamine release in the rat striatum: an in vivo microdialysis study.
    Butcher SP, Fairbrother IS, Kelly JS, Arbuthnott GW.
    J Neurochem; 1988 Feb 23; 50(2):346-55. PubMed ID: 2447237
    [Abstract] [Full Text] [Related]

  • 11. Comparison of the effects of dopamine D1 and D2 receptor antagonists on rat striatal, limbic and nigral dopamine synthesis and utilisation.
    Magnusson O, Mohringe B, Fowler CJ.
    J Neural Transm; 1987 Feb 23; 69(3-4):163-77. PubMed ID: 2957465
    [Abstract] [Full Text] [Related]

  • 12. Partial lesions of the nigrostriatal pathway in the rat. Acceleration of transmitter synthesis and release of surviving dopaminergic neurones by drugs.
    Hefti F, Enz A, Melamed E.
    Neuropharmacology; 1985 Jan 23; 24(1):19-23. PubMed ID: 2858830
    [Abstract] [Full Text] [Related]

  • 13. Age effects on monoamine turnover of the rat substantia nigra.
    Venero JL, Machado A, Cano J.
    Brain Res; 1991 Aug 23; 557(1-2):109-14. PubMed ID: 1747745
    [Abstract] [Full Text] [Related]

  • 14. gamma-Butyrolactone-sensitive and -insensitive dopamine release, and their relationship to dopamine metabolism in three rat brain regions.
    Chrapusta SJ, Karoum F, Egan MF, Wyatt RJ.
    Eur J Pharmacol; 1992 Nov 03; 222(1):129-35. PubMed ID: 1468488
    [Abstract] [Full Text] [Related]

  • 15. D1 dopamine receptor stimulation enables the postsynaptic, but not autoreceptor, effects of D2 dopamine agonists in nigrostriatal and mesoaccumbens dopamine systems.
    Wachtel SR, Hu XT, Galloway MP, White FJ.
    Synapse; 1989 Nov 03; 4(4):327-46. PubMed ID: 2532422
    [Abstract] [Full Text] [Related]

  • 16. Effects of acute administration of SCH 23390 on dopamine and serotonin turnover in major dopaminergic areas and mesencephalic raphe nuclei--comparison with ritanserin.
    Lappalainen J, Hietala J, Koulu M, Sjöholm B, Syvälahti E.
    Prog Neuropsychopharmacol Biol Psychiatry; 1991 Nov 03; 15(6):861-72. PubMed ID: 1722342
    [Abstract] [Full Text] [Related]

  • 17. Characterization of dopamine release in the substantia nigra by in vivo microdialysis in freely moving rats.
    Robertson GS, Damsma G, Fibiger HC.
    J Neurosci; 1991 Jul 03; 11(7):2209-16. PubMed ID: 1712381
    [Abstract] [Full Text] [Related]

  • 18. Pharmacokinetic, neurochemical, stereological and neuropathological studies on the potential effects of paraquat in the substantia nigra pars compacta and striatum of male C57BL/6J mice.
    Breckenridge CB, Sturgess NC, Butt M, Wolf JC, Zadory D, Beck M, Mathews JM, Tisdel MO, Minnema D, Travis KZ, Cook AR, Botham PA, Smith LL.
    Neurotoxicology; 2013 Jul 03; 37():1-14. PubMed ID: 23523781
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Comparison of effects of drugs on dopamine metabolism in the substantia nigra and the corpus striatum of rat brain.
    Westerink BH, Korf J.
    Eur J Pharmacol; 1976 Nov 03; 40(1):131-6. PubMed ID: 991922
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.